In this episode, we explore three off-label but evidence-supported medications — gabapentin, topiramate, and baclofen — for alcohol use disorder, examining their mechanisms, dosing strategies, tolerability challenges, and which patients are most likely to benefit when first-line treatments have failed.

Faculty: Kevin A. Sevarino, M.D.C.M., Ph.D.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CMEs: Pharmacotherapy of Alcohol Use Disorder
• Gabapentin, Topiramate, and Baclofen for Alcohol Use Disorder